Literature DB >> 3062133

Dystrophin and nebulin in the muscular dystrophies.

K Patel1, T Voit, M J Dunn, P N Strong, V Dubowitz.   

Abstract

Skeletal muscle from patients with 5 different forms of muscular dystrophy and from 6 fetuses at high risk (95%) for Duchenne muscular dystrophy (DMD) were probed with specific antibodies for the presence of dystrophin and nebulin. Dystrophin was absent in all 5 patients with DMD and 4 of 6 fetuses at high risk for DMD and present in trace amounts in the remaining two. Dystrophin was also undetectable in one borderline DMD/Becker muscular dystrophy (BMD) case and reduced in 2 of 4 cases of BMD. In contrast, dystrophin was present in all 16 biopsies from 4 other types of muscular dystrophy (congenital, limb girdle, Emery-Dreifuss and facioscapulohumeral). Nebulin profiles varied with the type, severity and duration of the dystrophic process. Nebulin was present in 5 of 6 DMD fetal samples but vastly reduced or absent in all samples of clinically manifest DMD.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3062133     DOI: 10.1016/0022-510x(88)90256-0

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  9 in total

1.  Heterogeneity of dystrophin expression in patients with Duchenne and Becker muscular dystrophy.

Authors:  L V Nicholson; M A Johnson; D Gardner-Medwin; S Bhattacharya; J B Harris
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

2.  Immunohistochemical studies show truncated dystrophins in the myotubes of three fetuses at risk for Duchenne muscular dystrophy.

Authors:  I B Ginjaar; E Bakker; M M van Paassen; J T den Dunnen; A Wessels; E E Zubrzycka-Gaarn; A F Moorman; G J van Ommen
Journal:  J Med Genet       Date:  1991-08       Impact factor: 6.318

3.  Exon skipping and translation in patients with frameshift deletions in the dystrophin gene.

Authors:  T G Sherratt; T Vulliamy; V Dubowitz; C A Sewry; P N Strong
Journal:  Am J Hum Genet       Date:  1993-11       Impact factor: 11.025

4.  Somatic mosaicism for a deletion of the dystrophin gene in a carrier of Becker muscular dystrophy.

Authors:  T Voit; E Neuen-Jacob; V Mahler; A Jauch; M Cremer
Journal:  Eur J Pediatr       Date:  1992-02       Impact factor: 3.183

5.  Evolutionary conservation of the dystrophin central rod domain.

Authors:  T G Sherratt; T Vulliamy; P N Strong
Journal:  Biochem J       Date:  1992-11-01       Impact factor: 3.857

6.  Congenital muscular dystrophy. A study on the variability of morphological changes and dystrophin distribution in muscle biopsies.

Authors:  Q H Leyten; H J ter Laak; F J Gabreëls; W O Renier; K Renkawek; R C Sengers
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

7.  Prenatal diagnosis of Duchenne muscular dystrophy by fetal muscle biopsy.

Authors:  J A Kuller; E P Hoffman; M H Fries; M S Golbus
Journal:  Hum Genet       Date:  1992 Sep-Oct       Impact factor: 4.132

8.  Dystrophin in frameshift deletion patients with Becker muscular dystrophy.

Authors:  S B Gangopadhyay; T G Sherratt; J Z Heckmatt; V Dubowitz; G Miller; M Shokeir; P N Ray; P N Strong; R G Worton
Journal:  Am J Hum Genet       Date:  1992-09       Impact factor: 11.025

9.  Differentiation of Duchenne and Becker muscular dystrophy phenotypes with amino- and carboxy-terminal antisera specific for dystrophin.

Authors:  D E Bulman; E G Murphy; E E Zubrzycka-Gaarn; R G Worton; P N Ray
Journal:  Am J Hum Genet       Date:  1991-02       Impact factor: 11.025

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.